| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 14, 2025 5:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 14, 2025 5:00 P.M. |
| Form: | S-1 | ||||||
| |||||||
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
8-K - GAXOS.AI INC. (0001895618) (Filer)
424B5 - GAXOS.AI INC. (0001895618) (Filer)
424B5 - GAXOS.AI INC. (0001895618) (Filer)
Caylent Named Development Partner to Lead AWS-Native Build Roseland, NJ, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced that Amazon Web Services ("AWS") has committed to fund the preliminary development of Gaxos Labs' innovative, AI-powered sales coaching platform, positioning Gaxos to compete in the multibillion- dollar sales technology market. The AWS-backed initiative, in collaboration with Caylent, an AWS premier partner, supports the development of a real-time, AI sales platform designed for enterprise-scale deployment, incorporating live call t
Roseland, NJ, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced the official launch of Bible Pray AI, a personalized, AI-powered spiritual growth platform designed to help users deepen faith, strengthen daily devotion, and apply scripture for greater peace, clarity, and purpose. Bible Pray AI represents Gaxos' strategic expansion into the rapidly growing digital faith, mental wellness, and personal development economy, a sector supported by hundreds of millions of engaged global users seeking guided spiritual content, daily motivation, and community-base
Roseland, NJ, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various high-growth sectors, today announced its participation in the upcoming WAWTech Conference, taking place on December 16-17, 2025 in Warsaw, Poland. "We're thrilled to take part in this year's WAWTech Conference ," said Vadim Mats, CEO of Gaxos. "This event offers a tremendous opportunity to engage with technology leaders and innovators across Europe, exchange ideas, and build partnerships that accelerate the growth and adoption of Gaxos AI offerings." To meet with Gaxos at the conferences or for press inquiries, please email pre
4 - GAXOS.AI INC. (0001895618) (Issuer)
4 - GAXOS.AI INC. (0001895618) (Issuer)
4 - GAXOS.AI INC. (0001895618) (Issuer)
Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell. "The addition of top medical talent to our Medical Advisory Board reflects our continued commitment to pursuing a best-in-class solution for Gaxos Health," said Vadim Mats, CEO of Gaxos.AI. "An advisory board of experts in their respective fields will allow to create a better product and advancing our mission of creating value for shareholders." Dr. Eric Margolis, M.D. is a Board-Ce
SC 13G - GAXOS.AI INC. (0001895618) (Subject)
Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that it had acquired the rights to use certain AI-enabled technology from a top biohacking app, "Ultiself," in order to facilitate the development of its tech for Gaxos Health. The integration of Ultiself's proprietary technology into Gaxos Health's proposed product offering will enable enhanced customization and user experience aligning with modern-day consumer's demands for custom and efficient solutions. This move is expected to accelerate Gaxos Health's development and help solidify its positio